Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Aquinox Pharmaceuticals Inc (NASDAQ:AQXP)

1.71
Delayed Data
As of Jul 29
 -0.06 / -3.39%
Today’s Change
1.38
Today|||52-Week Range
12.28
-77.20%
Year-to-Date
No recent news for Aquinox Pharmaceuticals Inc.

Today’s Trading

Previous close1.77
Today’s open1.77
Day’s range-- - --
Volume287,676
Average volume (3 months)97,366
Market cap$18.3M
Dividend yield--
Data as of 07/29/2015

Growth & Valuation

Earnings growth (last year)-216.09%
Earnings growth (this year)+21.33%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book0.51

Competitors

 Today’s
change
Today’s
% change
CAPNCapnia Inc-0.11-4.31%
ECTEEcho Therapeutics In...-0.01-0.57%
ALXAAlexza Pharmaceutica...+0.04+3.96%
DARADARA BioSciences Inc-0.02-1.76%
Data as of 07/29/2015

Financials

Next reporting dateAugust 7, 2015
EPS forecast (this quarter)-$0.54
Annual revenue (last year)$0.00
Annual profit (last year)-$23.8M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
David J. Main
Chief Financial Officer &
Vice President
Kamran Alam
Corporate headquarters
Vancouver, British Columbia

Forecasts